Pharmafile Logo
Pharmafocus logo
Advanced Search

Nuance Pharma Announces Dosing of First Patient in ENHANCE – China Phase 3 Trial for COPD

April 11, 2023
Business Services

LONDON and RALEIGH, N.C., April 11, 2023 – Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage …

News
Press release

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

April 11, 2023
Business Services

Leiden, The Netherlands, April 11, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces the first commercial …

News
Press release

Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical Study

April 6, 2023
Business Services

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces the opening …

News
Press release
christina-victoria-craft-whsnkiwwpec-unsplash_4

AstraZeneca’s Lynparza approved by NHS England

April 6, 2023
Medical Communications

NHS England has approved the use of AstraZeneca’s Lynparza (olaparib) for the treatment of patients with breast cancer and prostate …

News
chuttersnap-oijvdm3zx4i-unsplash

Synapse receives FDA approval for its NeuRx DPS to treat patients with stable SCI

April 6, 2023
Research and Development

Synapse Biomedical has announced that it has gained premarket approval (PMA) from the FDA for its NeuRxDiaphragm Pacing System (NeuRx …

News

Innova Care Concepts expand their support to the medical negligence sector with the acquisition of Nurture Group Ltd.

April 5, 2023
Business Services

Press Release, Wednesday 5th April 2023, London… As part of a long-term strategy to increase its home adaptation services across …

News
Press release

Ipsen’s response to NICE’s decision on Cabometyx® (cabozantinib) for previously treated differentiated thyroid cancer unsuitable for or refractory to radioactive iodine

April 5, 2023
Business Services

  SLOUGH, UK, 5th April 2023 – Ipsen is disappointed that the National Institute for Health and Care Excellence (NICE) …

News
Press release

Syncona Appoints Roel Bulthuis as Managing Partner

April 5, 2023
Business Services

05 April 2023   Syncona Ltd, a leading healthcare company focused on creating, building and scaling global leaders in life …

Appointment

First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation Study

April 5, 2023
Business Services

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the …

News
Press release

BenevolentAI announces top-line Phase IIa results for its topical pan-Trk inhibitor BEN-2293 (1%) in mild-to-moderate atopic dermatitis

April 5, 2023
Business Services

London, UK, 5 April 2023: BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI) announces top-line results from its Phase IIa, …

News
Press release

AstraZeneca reports positive results of drug combination in late-stage ovarian cancer trial

April 5, 2023
Medical Communications

AstraZeneca has announced positive high-level results from an interim analysis of the DUO-O phase 3 trial assessing a combination of …

News
hal-gatewood-ipl3q-gegzy-unsplash_2

FDA requires prepaid mail-back envelopes for opioid analgesics

April 5, 2023
Medical Communications

The FDA has announced that it will require opioid analgesic manufacturers to provide prepaid mail-back envelopes in outpatient pharmacies and …

News

Phlo acquires Truepill UK in landmark digital pharmacy consolidation

April 4, 2023
Business Services

Glasgow, UK. Phlo Technologies UK digital pharmacy leaders, have today announced their acquisition of the UK arm of US-based healthcare …

News
Press release

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

April 4, 2023
Business Services

Cambridge, UK, 04 April 2023 – Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company dedicated to resolving …

News
Press release

Recipharm bolsters senior leadership team with appointment of Joaquim Mascaro as Chief Financial Officer

April 4, 2023
Business Services

Global contract development and manufacturing organisation (CDMO) Recipharm, has announced the appointment of Joaquim Mascaro as Chief Financial Officer.

Appointment
optibrium_appointment

Optibrium Appoints Computational Modelling Expert, Dr Hamed Tabatabaei Ghomi as Head of Research

April 4, 2023
Business Services

Appointment will lead research strategy to apply the latest scientific innovations to Optibrium’s computational and AI drug discovery technologies Hamed …

Appointment

Landmark data published on successful NTCD-M3 gut colonisation after fidaxomicin administration

April 4, 2023
Business Services

Brighton, United Kingdom – 4 April 2023 – Destiny Pharma (AIM: DEST), a clinical stage innovative biotechnology company focused on …

News
Press release

PHARMANOVIA RECEIVES SBTi APPROVAL FOR NET ZERO EMISSION TARGETS

April 4, 2023
Business Services

Basildon, UK, 3 April 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of already established …

News
Press release
steve_jones_chief_financial_officer_for_ingenza

Ingenza appoints Steve Jones as its new Chief Financial Officer

April 4, 2023
Business Services Ingenza

  Ingenza appoints Steve Jones as its new Chief Financial Officer  

Appointment

Orbit Discovery and Evergreen Discovery collaborate to discover peptides for targeting radiopharmaceuticals

April 4, 2023
Business Services

New Jersey, USA, and Oxford, UK, 3rd April 2023: Evergreen Discovery (Evergreen), a leading radiopharmaceutical drug development company with a …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025